Cosmetic cross-reference Noindex: medium evidence

Carbon

CAS 7440-44-0

Carbon (CAS 7440-44-0) is a pharmaceutical compound with 0 bioactivity targets and 742 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
742
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Carbon
CAS Number
7440-44-0
Molecular Formula
C
InChIKey
OKTJSMMVPCPJKN-UHFFFAOYSA-N
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID9027651

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Carbon is linked to DTXSID9027651 in DSSTox identifiers.

View industrial chemical data →
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Carbon used for in pharmaceutical contexts?

Carbon (CAS 7440-44-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Carbon?

Carbon has 742 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Acidosis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Carbon also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Activated Charcoal (Charcoal Powder) with EU status "permitted".

What clinical phase is Carbon in?

No phase 1-4 clinical development badge is rendered for Carbon because the matched compound identifier rows do not contain a max-phase value.